Screening and Diagnosis of Diabetes

Introduction to Screening Guidelines

The American Diabetes Association recommends screening for diabetes in adults aged 35-45 years or earlier if overweight/obese with risk factors, using fasting plasma glucose (FPG ≥126 mg/dL) or A1C (≥6.5%) 1, 2, 3

The American Diabetes Association recommends starting screening at age 45 years for those without additional risk factors 1, 2, 4
Screen at age 40-70 years if BMI ≥25 kg/m² 2
Screen earlier than age 35-45 if BMI ≥25 kg/m² (≥23 kg/m² for Asian Americans) with any additional risk factor, such as first-degree relative with diabetes, high-risk ethnicity, hypertension, HDL cholesterol <35 mg/dL and/or triglycerides >250 mg/dL, physical inactivity, women with prior gestational diabetes or delivered baby >9 lb, polycystic ovary syndrome (PCOS), previous impaired fasting glucose (IFG) or impaired glucose tolerance (IGT), or history of cardiovascular disease 1, 5, 4

Fasting plasma glucose (FPG) is the most practical, reproducible, and cost-effective screening test 6, 1, 7
A1C is a convenient alternative, with no fasting required 6, 1

Screen every 3 years if initial screening is normal 1, 7, 2, 4
Screen more frequently (annually or more often) for patients with borderline results or multiple risk factors 1, 5, 3

Impaired fasting glucose (IFG): FPG 100-125 mg/dL (5.6-6.9 mmol/L) 6, 1
Impaired glucose tolerance (IGT): 2-hour OGTT 140-199 mg/dL (7.8-11.0 mmol/L) 6, 1
A1C 5.7-6.4% is a pre-diabetes category 6, 1

Do not wait until age 45 for overweight/obese patients with risk factors—screen immediately 4
Always confirm abnormal results with repeat testing on a separate day unless patient has unequivocal hyperglycemic symptoms 6, 1, 8
Do not rely on random blood glucose alone for screening—sensitivity is only 39-55% 6
Avoid community screening outside healthcare settings—ensures proper follow-up and appropriate targeting of high-risk populations 1
Do not use A1C alone to rule out diabetes—values <6.5% do not exclude diabetes if FPG or OGTT are elevated 6

Adults with hypertension or hyperlipidemia should be screened for diabetes regardless of age because detection markedly improves cardiovascular risk stratification and permits aggressive blood‑pressure and lipid management that reduces cardiovascular events and mortality. 9, 10, 11, 12

Fasting plasma glucose (FPG) is the preferred initial screening test because it is practical, reproducible, cost‑effective, shows less intra‑individual variation, and is more convenient for patients than alternative methods. 13, 9, 14, 10, 15

Random capillary blood glucose screening has only about 75 % sensitivity even when age and time since the last meal are considered, making it unsuitable as a sole screening tool. 9, 14, 10, 15
The 2‑hour oral glucose tolerance test (OGTT) is more cumbersome, less reproducible, and less acceptable to patients, although it may identify additional cases of diabetes. 13, 9, 14, 15

Diabetes is diagnosed when any of the following criteria are met:
- Fasting plasma glucose ≥ 126 mg/dL (7.0 mmol/L) after an 8‑hour fast. 13, 9, 14, 10, 15
- 2‑hour plasma glucose ≥ 200 mg/dL (11.1 mmol/L) during a 75‑g OGTT. 13, 9, 14, 10, 15

Abnormal screening results must be confirmed with repeat testing on a separate day, especially for borderline values or in asymptomatic individuals. 13, 9, 14, 10, 15

If the initial screening is normal, repeat screening every 3 years. 13, 9, 14, 10, 15
More frequent screening (annually or more often) is indicated for high‑risk populations, including those with multiple risk factors or pre‑diabetic results. 13, 9, 14, 10, 15

Incorporating diabetes screening into cardiovascular risk reduction for patients with hypertension or hyperlipidemia enables:
- Lower diastolic blood‑pressure targets < 80 mm Hg. 9, 10, 11
- Lower LDL‑cholesterol targets. 9, 14, 10, 15
- More aggressive management of other modifiable risk factors. 13, 9, 15